Emma Kaufman is an associate practicing in Ropes & Gray’s health care group. Emma provides transactional, regulatory, and compliance advice to a range of health care clients, including pharmaceutical and medical device manufacturers, wholesalers, distributors, pharmacies, hospitals, hospice and home health providers, and health care focused-private equity funds.
Emma advises clients on compliance with health care regulatory laws, including federal and state fraud and abuse laws, HIPAA, and state laws governing licensure and changes of ownership. Emma also counsels clients on internal as well as external investigations into alleged noncompliance with policies, procedures, and health care regulatory laws, including with respect to alleged research misconduct.
Emma maintains an active pro bono practice and currently serves as a family law team lead for Ropes & Gray’s medical-legal partnership with Dorchester House in Boston.
Experience
- Health Care Transactions. Advises health care providers in acquisitions, joint ventures, and strategic transactions and advises pharmaceutical manufacturers in strategic transactions.
- Private Equity. Advises on a variety of private equity transactions in the health care space including investments in contract manufacturing and contract development and manufacturing organizations, clinical research organizations, hospice and home health providers, pharmaceutical manufacturers, wholesale distributors and pharmacies.
- Enforcement. Advises health plans and providers subject to health care investigations and audits by federal and state enforcement agencies such as the New York Medicaid Fraud Control Unit, Centers for Medicare & Medicaid Services, and National Institutes of Health.
- Licensure. Advises clients navigating complex licensure change of ownership and certificate of need requirements in connection with transactions.
- HIPAA. Advises clients in connection with HIPAA breach investigations by the United States Department of Health and Human Services, Office for Civil Rights.
- Research Misconduct. Advises health care and research institutions in connection with investigations regarding research misconduct.
- FEMA. Advises clients on issues associated with the COVID-19 pandemic, including arbitrations of denials for financial assistance under FEMA’s Public Assistance Program.